Recent Updates
Recently added Catalysts
EUDA Negative Sentiment Score: 35/100

EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Singapore

Key Takeaway: EUDA Health Holdings Limited has received a delinquency notification letter from Nasdaq due to its failure to timely file its Quarterly Report on Form 10-Q. This follows a similar notice received earlier for not submitting the Annual Report on Form 10-K. The company has until June 5, 2023, to propose a plan for regaining compliance, with a potential extension until September 27, 2023, to file the required reports. Failure to comply may result in the delisting of its securities from Nasdaq.

Market Sentiment Analysis

CONCERNS & RISKS

  • EUDA received a delinquency notice from Nasdaq for failure to file required reports.
  • The company may face delisting if it fails to regain compliance with Nasdaq rules.
  • There is uncertainty regarding the company's financial reporting timeline.

Full Press Release Details

Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter
May 19, 2023 - EUDA Health Holdings Limited (the "Company" or "EUDA") (NASDAQ: EUDA, EUDAW), a Singapore-based
health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, announced today that it received
a delinquency notification letter ("Notice") from the Listing Qualifications Staff (the "Staff") of the Nasdaq
Stock Market LLC ("Nasdaq") on May 18, 2023 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1)
as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023
(the "Form 10-Q"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial
reports with the Securities and Exchange Commission (the "SEC").
reported on April 10, 2023, the Company has received a similar notice from Nasdaq on April 5, 2023 as a result of the Company's
failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The Notice states that the Company
has up to June 5, 2023 to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company's
plan, then Nasdaq may grant the Company up to September 27, 2023 for filing the Form 10-K and the Form 10-Q to regain compliance. If
Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings
Panel. If our appeal fails, the Company's securities may be delisted.
of the Company has been working diligently to complete all of the required information for the Form 10-K and Form 10-Q, and a substantial
part of such information has been completed as of this date. However, the Company requires additional time to prepare, review and finalize
its financial statements.
Notice has no immediate impact on the listing of the Company's common stock, which will continue to trade on Nasdaq under the symbol
announcement is made in compliance with Nasdaq Listing Rule 5250(b)(2).
EUDA Health Holdings Limited
Health Holdings Limited is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare
ecosystem aimed at making healthcare affordable and accessible, and improving the patient experience by delivering better outcomes through
personalized healthcare. The company's proprietary unified AI platform quickly assesses patients' medical history, triages
conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. EUDA's holistic approach supports
patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and
announcement contains forward-looking statements, including statements about the financial condition, results of operations, earnings
outlook and prospects of the Company. In addition, any statements that refer to projections, forecasts or other characterizations of
future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are
typically identified by words such as "plan," "believe," "expect," "anticipate," "intend,"
"outlook," "estimate," "forecast," "project," "continue," "could,"
"may," "might," "possible," "potential," "predict," "should,"
"would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.
forward-looking statements are based on the current expectations of the Company's management and are inherently subject to uncertainties
and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that
future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties
or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these
forward-looking statements. These risks and uncertainties include, but are not limited to, those discussed and identified in public filings
made with the SEC by the Company.

Frequently Asked Questions

What was the nature of the Nasdaq letter received by EUDA?

EUDA received a delinquency notification from Nasdaq for not filing its Form 10-Q.

What triggers a delinquency notice from Nasdaq?

A delinquency notice is issued due to non-compliance with filing periodic financial reports.

What is the deadline for EUDA to submit a compliance plan?

EUDA must submit a plan to Nasdaq by June 5, 2023, to regain compliance.

What happens if EUDA's compliance plan is not accepted?

If not accepted, EUDA can appeal to a Nasdaq Hearings Panel to avoid delisting.

Is EUDA's stock currently impacted by this notice?

The notice does not immediately affect the trading of EUDA's common stock on Nasdaq.

Last updated: May 19, 2023